Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06711146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06711146 · ClinicalTrials.gov record · last posted 2026-08-24

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research

Name: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research — clinical trial record (NCT06711146)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseEarly Phase 1

SponsorZhejiang University

Started2024-12-24

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

A Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Moderate to Severe Active Systemic Lupus Erythematosus

Protocol amendment history 1 change detected by DataLookout

2026-08-25

Primary endpoint(s) modified

Was~~DCR~~, MTD

NowDLTs, Incidence of treatment-emergent adverse events(TEAEs), MTD

Trial Details

NCT Number	NCT06711146
Lead Sponsor	Zhejiang University Collaborators: Leman Biotech Co., Ltd.
Conditions	Systemic Lupus Erythematosus
Enrollment	36 participants
Start Date	2024-12-24
Primary Completion	2026-12-01 (estimated)
Study Completion	2027-04-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-24